Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Vertex Rises After FDA Staff Finds Hepatitis Drug EffectiveBloombergBy Molly - Tue Apr 26 20:13:27 GMT 2011 Vertex Pharmaceuticals Inc. (VRTX) jumped 10 percent in Nasdaq stock market trading after US regulators said the company's experimental hepatitis C drug cures more patients than current therapies. ...See all stories on this topic »

FDA backs Vertex hepatitis drug efficacy, shares jumpReutersBy Richwine WASHINGTON (Reuters) - A hepatitis C drug from Vertex Pharmaceuticals Inc cured more patients than previously reported, US health reviewers said, boosting the approval chances for a pill expected to transform treatment of the ...See all stories on this topic »

Hepatitis C claims two more in wrestlingExaminer.com--Desmon Wolfe, former ROH Heavyweight Champion and currently on the TNA roster has allegedly been diagnosed with Hepatitis C which is why he has not been in a TNA ring since August. Wolfe is looking at taking an office role with the company. ...See all stories on this topic »

Some Biotechs May Benefit From Hepatitis C Treatment Market ShiftSeeking AlphaThe landscape for treating hepatitis C virus is on the verge of dramatic change due to the development of new classes of drugs offering significant improvements in efficacy, convenience and tolerability over the current standard of care which is ...See all stories on this topic »

Regulators to weigh risks, benefits of experimental drug to treat Hepatitis CNews 10NBCFederal regulators will weigh the risks and benefits of an experimental drug to treat Hepatitis C this week. Advisors to the food and drug administration are scheduled to meet Wednesday to discuss Merck's hepatitis drug called "Boceprevir. ...See all stories on this topic »

Boehringer Ingelheim Announces Enrollment of First Patient in Phase 3 Trial ...PR Newswire (press release)... Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).

....See all stories on this topic »

Frequency Distribution of HCV genotypes among Chronic Hepatitis C Patients ...7thSpace Interactive (press release)Hepatitis C Virus (HCV) genotypes frequency is important for the predication of response to therapy and duration of treatment. Despite variable response rates experienced in the case of Interferon (IFN) -based therapies, there was scarcity of data on ...See all stories on this topic »

AGA Digestive Health Outcomes Registryâ„¢, Powered by MedAssurant Healthcare ...PR Newswire (press release)The clinical insight gained from this large-scale analysis of real-world data will support development efforts in the treatment of various gastroenterological diseases, including hepatitis C. "The AGA Digestive Health Outcomes Registry is an important

....See all stories on this topic »

Pharmasset 2Q loss widens on costsBusinessWeekAnalysts polled by FactSet projected a loss of 66 cents per share and revenue of $260000. Costs and expenses jumped 32 percent to $20.8 million, mainly on research and development costs. Pharmasset is developing potential hepatitis C treatments.See all stories on this topic »